Rezolute Inc (RZLT)
2.76
+0.20
(+7.81%)
USD |
NASDAQ |
May 20, 10:36
Rezolute Enterprise Value: 25.93M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 25.93M |
| May 16, 2024 | 22.72M |
| May 15, 2024 | 26.34M |
| May 14, 2024 | 27.54M |
| May 13, 2024 | 34.36M |
| May 10, 2024 | 39.97M |
| May 09, 2024 | 34.35M |
| May 08, 2024 | 37.16M |
| May 07, 2024 | 35.56M |
| May 06, 2024 | 51.21M |
| May 03, 2024 | 52.81M |
| May 02, 2024 | 39.17M |
| May 01, 2024 | 30.74M |
| April 30, 2024 | 27.53M |
| April 29, 2024 | 24.72M |
| April 26, 2024 | 26.73M |
| April 25, 2024 | 24.32M |
| April 24, 2024 | 35.96M |
| April 23, 2024 | 34.76M |
| April 22, 2024 | 62.05M |
| April 19, 2024 | 57.63M |
| April 18, 2024 | 52.41M |
| April 17, 2024 | 50.01M |
| April 16, 2024 | 56.43M |
| April 15, 2024 | 43.58M |
| Date | Value |
|---|---|
| April 12, 2024 | 28.33M |
| April 11, 2024 | 24.32M |
| April 10, 2024 | 17.10M |
| April 09, 2024 | 20.31M |
| April 08, 2024 | 21.51M |
| April 05, 2024 | 14.69M |
| April 04, 2024 | 12.68M |
| April 03, 2024 | 15.49M |
| April 02, 2024 | 11.88M |
| April 01, 2024 | 17.10M |
| March 28, 2024 | 9.727M |
| March 27, 2024 | -2.712M |
| March 26, 2024 | -7.528M |
| March 25, 2024 | -16.76M |
| March 22, 2024 | -12.34M |
| March 21, 2024 | -15.55M |
| March 20, 2024 | -15.95M |
| March 19, 2024 | -16.36M |
| March 18, 2024 | -20.77M |
| March 15, 2024 | -22.06M |
| March 14, 2024 | -20.48M |
| March 13, 2024 | -16.52M |
| March 12, 2024 | -15.33M |
| March 11, 2024 | -13.35M |
| March 08, 2024 | -17.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-103.50M
Minimum
Dec 19 2022
194.45M
Maximum
Oct 14 2020
13.47M
Average
14.26M
Median
Mar 06 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.05M |
| Total Expenses (Quarterly) | 16.21M |
| EPS Diluted (Quarterly) | -0.34 |
| Earnings Yield | -41.30% |